SMC Ltd. Announces Expansion of Sterile Fill Finish Capabilities, Unveiling State-of-the Art Facility in North Carolina

SMC Ltd. announces expansion of sterile fill finish capabilities, unveiling state-of-the-art facility in North Carolina. The facility enables SMC to offer a wider portfolio of services to its pharma clients including lab to market development, analytical services, device manufacture, fill finish, final assembly, and secondary packaging.

The new facility compliments SMC’s footprint of global manufacturing capabilities and illustrates SMC’s commitment to the pharma services industry by offering high-speed, sterile fill finish lines with onsite formulation, compounding, and packaging capabilities. Read the full press release here.